Abstract
Objective
Evidence suggests that abnormal iron metabolism is associated with Parkinson disease (PD), with raised iron levels found in pathologically affected areas in PD. It is unknown if this elevated iron is actually associated with neurons or reactive glia, and we therefore addressed this issue by determining if raised iron was present in single dopaminergic neurons.Methods
We used unfixed frozen sections from postmortem tissue of PD patients and elderly normal individuals to avoid metal contamination and translocation. Levels of iron and other elements were measured using sensitive and specific wavelength dispersive electron probe x-ray microanalysis coupled with cathodoluminescence spectroscopy in individual substantia nigra dopaminergic neurons.Results
We identified raised intraneuronal iron in single defined substantia nigra neurons in PD (mean neuronal iron 2,838 vs 1,611, p < 0.0001) but not in other movement disorders such as Huntington disease. These findings were unrelated to the density of remaining neurons.Conclusions
Primary changes in neuronal iron could lead to neurodegeneration in Parkinson disease.Full text links
Read article at publisher's site: https://doi.org/10.1212/01.wnl.0000262033.01945.9a
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/102660382
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1212/01.wnl.0000262033.01945.9a
Article citations
Nanoscale synchrotron x-ray analysis of intranuclear iron in melanised neurons of Parkinson's substantia nigra.
Commun Biol, 7(1):1024, 20 Aug 2024
Cited by: 0 articles | PMID: 39164395 | PMCID: PMC11335769
The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases.
Int J Mol Sci, 25(8):4269, 12 Apr 2024
Cited by: 5 articles | PMID: 38673855 | PMCID: PMC11049980
Review Free full text in Europe PMC
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.
Int J Mol Sci, 24(21):15721, 29 Oct 2023
Cited by: 9 articles | PMID: 37958705 | PMCID: PMC10649239
Review Free full text in Europe PMC
A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels.
Nat Metab, 5(9):1595-1614, 31 Aug 2023
Cited by: 6 articles | PMID: 37653044 | PMCID: PMC11151872
Autolysis Affects the Iron Cargo of Ferritins in Neurons and Glial Cells at Different Rates in the Human Brain.
Cell Mol Neurobiol, 43(6):2909-2923, 15 Mar 2023
Cited by: 1 article | PMID: 36920627 | PMCID: PMC10333380
Go to all (154) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Exp Neurol, 166(1):127-135, 01 Nov 2000
Cited by: 291 articles | PMID: 11031089
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
Neurosci Lett, 414(1):94-97, 29 Dec 2006
Cited by: 146 articles | PMID: 17196747
Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.
Neurochem Int, 51(1):32-36, 31 Mar 2007
Cited by: 31 articles | PMID: 17490790
The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
IUBMB Life, 48(2):139-141, 01 Aug 1999
Cited by: 15 articles | PMID: 10794588
Review
Funding
Funders who supported this work.
Engineering and Physical Sciences Research Council (1)
Grant ID: EP/D066654/1
NIA NIH HHS (1)
Grant ID: R01 AG02030-01